Elephas Stock

elephas.comHealthcareFounded: 2020

Elephas specializes in development and research for novel cancer diagnostic solutions, treatments, and drug therapies. Elephas' primary solution is its imaging platform technology, designed to assess how live tumor fragments respond to cancer therapies, thus removing trial-and-error approaches to cancer care. Elephas' mission is to advance multimodal microscopy, and AI to accelerate drug treatments and empower clinical decision making.

Register for Details

For more details on financing and valuation for Elephas, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Elephas.

Register Today

Other companies like Elephas in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM

News

ARCH Venture Partners led the round, and were joined by new investors, Moore Strategic Ventures and Tao Capital Partners. Continuing investments were made by Northpond Ventures, Sands Capital, and WARF Ventures. Prior investments include $20 million from the Series A and $8 million from the founder and early seed investors.